---
title: "Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose via... — FDA record D-0003-2023 | Is It on Recall"
description: "Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial."
url: https://isitonrecall.com/recall/fda-drug-d-0003-2023-aminophylline-injection-usp-250-mg-10-ml-25-mg-ml-25x10-ml-single-dose-vial-rx-only-distributed-by-h/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc.... — FDA record D-0003-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 27, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)
- **Reason**: Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
- **Classification**: Class II
- **Recalling firm**: Pfizer Inc.
- **Quantity**: 103,150 10 mL vials
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0003-2023

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0003-2023%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot: 30-137-DK Exp. 1 DEC. 2022 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Distributed in the United States and Puerto Rico.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Report date**: Oct 12, 2022
- **Recall initiation date**: Sep 27, 2022
- **Center classification date**: Oct 4, 2022
- **Termination date**: Aug 21, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0003-2023%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Pfizer Inc. records](https://isitonrecall.com/brand/pfizer-inc/)